4,5,6,7-Tetrahydro-5α-methyl-6-(3-methyl-2-butenyl)-8-chloroimidazo[4,5,1-jk][1,4]benzodiazepine-2(1H)-thione
4,5,6,7-Tetrahydro-5α-methyl-6-(3-methyl-2-butenyl)-8-chloroimidazo[4,5,1-jk][1,4]benzodiazepine-2(1H)-thione Basic information
- Product Name:
- 4,5,6,7-Tetrahydro-5α-methyl-6-(3-methyl-2-butenyl)-8-chloroimidazo[4,5,1-jk][1,4]benzodiazepine-2(1H)-thione
- Synonyms:
-
- (5S)-6-(3-Methyl-2-butenyl)-4,5,6,7-tetrahydro-5α-methyl-8-chloroimidazo[4,5,1-jk][1,4]benzodiazepine-2(1H)-thione
- 4,5,6,7-Tetrahydro-5α-methyl-6-(3-methyl-2-butenyl)-8-chloroimidazo[4,5,1-jk][1,4]benzodiazepine-2(1H)-thione
- 8-Chloro-TIBO
- R-86183
- (+)-(S)-4,5,6,7-Tetrahydro-8-chloro-5-methyl-6-(3-methyl-2-butenyl)imidazo[4,5,1-jk][1,4]benzodiazepine-2-(1H)-thione
- 8-Cltibo
- Aids002738
- Aids-002738
- CAS:
- 137332-54-8
- MF:
- C16H20ClN3S
- MW:
- 321.874
- Mol File:
- 137332-54-8.mol
More
Less
4,5,6,7-Tetrahydro-5α-methyl-6-(3-methyl-2-butenyl)-8-chloroimidazo[4,5,1-jk][1,4]benzodiazepine-2(1H)-thione Usage And Synthesis
Uses
Tivirapine (R86183) is a nonnucleoside HIV-1 RT inhibitor against HIV-1-induced cytopathic effects with an EC50 value of 4 nM. Tivirapine inhibits the Yl8lC mutant of HIV-1 RT[1].
References
[1] Ding J, et al. Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors. Nat Struct Biol. 1995 May;2(5):407-15. DOI:10.1038/nsb0595-407
[2] Zhou Z, et al. Relative free energy of binding and binding mode calculations of HIV-1 RT inhibitors based on dock-MM-PB/GS. Proteins. 2004 Nov 15;57(3):493-503. DOI:10.1002/prot.20223
4,5,6,7-Tetrahydro-5α-methyl-6-(3-methyl-2-butenyl)-8-chloroimidazo[4,5,1-jk][1,4]benzodiazepine-2(1H)-thioneSupplier
Suzhou Meishi Biotechnology Co., Ltd.
- Tel
- 1173954148q
- meishipharma@126.com
TargetMol Chemicals Inc.
- Tel
- 15002134094
- marketing@targetmol.cn
TargetMol Chemicals Inc.
- Tel
- +17819995354
- marketing@targetmol.com
TargetMol Chemicals Inc.
- Tel
- +1-781-999-5354;
- support@targetmol.com